Renue By Science

Liposomal NAD+ Complete Oral Spray

F
N+ Score33
Longevity & NAD+Serving: 1 Spray(s)Type: Other Combinations

Renue By Science's Liposomal NAD+ Complete Oral Spray is a longevity and NAD+ category supplement, featuring a single active ingredient: a Liposomal NAD Complex. This product is delivered as an oral spray, with 120 servings per container. It received an N+ Score of 33, earning an 'F' grade, which signifies a poor overall quality assessment from Nutrienting.com. The product's formula completeness is rated at 25, and its label transparency is 0, indicating a significant lack of detailed information regarding the specific composition and dosages within the 'Liposomal NAD Complex.' There are no ingredients identified as being at clinical doses, nor are any specifically listed as underdosed due to the proprietary nature of the complex. This product may appeal to those interested in NAD+ support via an oral spray, but the low N+ Score and lack of label transparency raise concerns regarding its potential efficacy and value.

About This Product

Liposomal NAD+ Complete Oral Spray by Renue By Science is a longevity & nad+ supplement containing 1 active ingredients. It has earned an N+ Score of 33/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency0/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity48/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Product data available for comparison

Weaknesses

  • Missing several expected ingredients for its category
  • Proprietary blends hide individual ingredient amounts

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
Liposomal NAD ComplexN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.